Serum low‐density lipoprotein (LDL, mmol/L) · adults with or without existing CVD
2 findings from 1 review
Myocardial infarction · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (high dose) showed no clear difference in myocardial infarction compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
1 finding from 1 review
Stroke · people with or without existing cardiovascular disease, men and women
It is very uncertain whether homocysteine‐lowering interventions (high dose) changes stroke compared with homocysteine‐lowering interventions (low dose) (very low certainty).
1 finding from 1 review
Death by any cause · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (high dose) showed no clear difference in death by any cause compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
1 finding from 1 review
Cancer · people with or without existing cardiovascular disease, men and women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serum low‐density lipoprotein (LDL, mmol/L) · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
Acute kidney injury · adults undergoing cardiac surgery with cardiopulmonary bypass
It is very uncertain whether high changes acute kidney injury compared with low blood pressure target (very low certainty).
1 finding from 1 review
Cognitive deterioration · adults undergoing cardiac surgery with cardiopulmonary bypass
High showed no clear difference in cognitive deterioration compared with low blood pressure target (low certainty).
1 finding from 1 review
All‐cause mortality · adults undergoing cardiac surgery with cardiopulmonary bypass
It is very uncertain whether high changes all‐cause mortality compared with low blood pressure target (very low certainty).
1 finding from 1 review
Quality of life · adults undergoing cardiac surgery with cardiopulmonary bypass
It is very uncertain whether high changes quality of life compared with low blood pressure target (very low certainty).
1 finding from 1 review
Acute ischaemic stroke · adults undergoing cardiac surgery with cardiopulmonary bypass
It is very uncertain whether high changes acute ischaemic stroke compared with low blood pressure target (very low certainty).
1 finding from 1 review
Length of hospital stay · adults undergoing cardiac surgery with cardiopulmonary bypass
1 finding from 1 review
Perioperative transfusion of blood products · adults undergoing cardiac surgery with cardiopulmonary bypass
1 finding from 1 review
All‐cause mortality – deaths · adults with or without existing CVD
High showed no clear difference in all‐cause mortality – deaths compared with low long‐chain omega‐3 fats (high certainty).
1 finding from 1 review
All‐cause mortality – deaths · adults with or without existing CVD
High showed no clear difference in all‐cause mortality – deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · adults with or without existing CVD
High showed no clear difference in cardiovascular mortality – cardiovascular deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
Cardiovascular events · adults with or without existing CVD
High showed no clear difference in cardiovascular events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
1 finding from 1 review
Coronary heart disease mortality – CHD deaths · adults with or without existing CVD
High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
CHD events · adults with or without existing CVD
High showed no clear difference in coronary heart disease events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
1 finding from 1 review
Stroke · adults with or without existing CVD
It is very uncertain whether high changes stroke compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).
1 finding from 1 review